Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Given New $18.00 Price Target at Mizuho

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) had its price objective decreased by analysts at Mizuho from $20.00 to $18.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Mizuho’s price target would indicate a potential upside of 248.77% from the stock’s current price.

Other analysts also recently issued research reports about the stock. Stifel Nicolaus reduced their target price on shares of Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating for the company in a report on Monday, May 11th. HC Wainwright decreased their target price on shares of Senseonics Holdings, Inc. Common Stock from $18.50 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, May 12th. Finally, Weiss Ratings lowered Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Senseonics Holdings, Inc. Common Stock currently has an average rating of “Moderate Buy” and an average target price of $17.20.

Senseonics Holdings, Inc. Common Stock Price Performance

SENS stock traded up $0.13 during trading hours on Wednesday, reaching $5.16. 315,486 shares of the stock were exchanged, compared to its average volume of 663,586. The company has a debt-to-equity ratio of 1.05, a quick ratio of 3.19 and a current ratio of 3.51. Senseonics Holdings, Inc. Common Stock has a 12 month low of $4.79 and a 12 month high of $12.58. The company has a market cap of $215.73 million, a P/E ratio of -2.58 and a beta of 0.99. The firm’s 50-day simple moving average is $6.12.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.71) EPS for the quarter, missing analysts’ consensus estimates of ($0.65) by ($0.06). Senseonics Holdings, Inc. Common Stock had a negative return on equity of 129.97% and a negative net margin of 213.87%.The business had revenue of $11.71 million during the quarter. As a group, equities research analysts forecast that Senseonics Holdings, Inc. Common Stock will post -2.38 earnings per share for the current year.

Insider Transactions at Senseonics Holdings, Inc. Common Stock

In related news, Director Douglas A. Roeder purchased 22,686 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The stock was acquired at an average price of $5.56 per share, for a total transaction of $126,134.16. Following the completion of the acquisition, the director owned 144,635 shares of the company’s stock, valued at $804,170.60. This represents a 18.60% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 4.70% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of SENS. Kestra Advisory Services LLC bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the first quarter worth $68,000. GSK plc bought a new stake in Senseonics Holdings, Inc. Common Stock in the fourth quarter worth $60,000. Townsend Asset Management Corp NC ADV bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter worth approximately $60,000. Cetera Investment Advisers purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the first quarter valued at about $85,000. Finally, Sanctuary Advisors LLC bought a new position in shares of Senseonics Holdings, Inc. Common Stock during the fourth quarter valued at approximately $71,000. Institutional investors own 12.36% of the company’s stock.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.